Lyka Labs (BOM:500259) Change In Receivables : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs Change In Receivables?

Lyka Labs's change in receivables for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Lyka Labs's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Lyka Labs's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-63 Mil. It means Lyka Labs's Accounts Receivable increased by ₹63 Mil from Mar. 2023 to Mar. 2024 .

Lyka Labs's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹270 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Lyka Labs's Days Sales Outstanding for the three months ended in Mar. 2024 was 88.70.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lyka Labs's liquidation value for the three months ended in Mar. 2024 was ₹-541 Mil.

Lyka Labs Change In Receivables Historical Data

The historical data trend for Lyka Labs's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Change In Receivables Chart

Lyka Labs Annual Data

Trend

Jun14

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

79.57

-7.30

-90.91

-12.53

-63.07

Lyka Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Lyka Labs Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Lyka Labs (BOM:500259) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lyka Labs's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	269.925	/	277.673	*	91
=	88.70

2. In Ben Graham's calculation of liquidation value, Lyka Labs's accounts receivable are only considered to be worth 75% of book value:

Lyka Labs's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	93.777	-	884.589	+	0.75 * 269.925	+	0.5 * 95.718
=	-541

Lyka Labs Change In Receivables Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs (BOM:500259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

LYKALABS:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines